CINECA IRIS Institutional Research Information System

Pharmacokinetic drug evaluation of ixazomib citrate for the treatment of multiple myeloma

Salvini, Marco
First
;Troia, Rossella;Giudice, Davide;Boccadoro, Mario;Larocca, Alessandra
Last
2018-01-01
2018
14
1
91
99
https://www.tandfonline.com/doi/abs/10.1080/17425255.2018.1417388?journalCode=iemt20
https://doi.org/10.1080/17425255.2018.1417388
Ixazomib; maintenance therapy; multiple myeloma; pharmacokinetics; proteasome inhibitors; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Boron Compounds; Dexamethasone; Glycine; Half-Life; Humans; Multiple Myeloma; Protease Inhibitors; Salvage Therapy; Thalidomide; Tissue Distribution; Toxicology; Pharmacology
Salvini, Marco; Troia, Rossella; Giudice, Davide; Pautasso, Chiara; Boccadoro, Mario; Larocca, Alessandra*
File in questo prodotto:
File Dimensione Formato  
[Author Vsn] Salvini et al - 2018 - Pharmacokinetic drug evaluation of ixazomib b.pdf

Open Access dal 02/02/2019

Descrizione: Author's version. Salvini M, Troia R, Giudice D, Pautasso C, Boccadoro M, Larocca A. Pharmacokinetic drug evaluation of ixazomib citrate for the treatment of multiple myeloma. Expert Opin Drug Metab Toxicol. 2018 Jan;14(1):91-99. doi: 10.1080/17425255.2018.1417388. Epub 2017 Dec 19. PMID: 29235380. © 2017 Informa UK Limited, trading as Taylor & Francis Group. The published version is available at: https://www.tandfonline.com/doi/abs/10.1080/17425255.2018.1417388?journalCode=iemt20 | https://doi.org/10.1080/17425255.2018.1417388 . When citing, please refer to the published version.
Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 772.88 kB
Formato Adobe PDF
Visualizza/Apri
772.88 kB Adobe PDF Visualizza/Apri
[Published Vsn] Salvini et al - 2018 - Expert Opin Drug Metab Toxicol - Pharmacokinetic drug.pdf

Accesso riservato

Descrizione: Restricted access - Published version. Salvini M, Troia R, Giudice D, Pautasso C, Boccadoro M, Larocca A. Pharmacokinetic drug evaluation of ixazomib citrate for the treatment of multiple myeloma. Expert Opin Drug Metab Toxicol. 2018 Jan;14(1):91-99. doi: 10.1080/17425255.2018.1417388. Epub 2017 Dec 19. PMID: 29235380. © 2017 Informa UK Limited, trading as Taylor & Francis Group. The published version is available at: https://www.tandfonline.com/doi/abs/10.1080/17425255.2018.1417388?journalCode=iemt20 | https://doi.org/10.1080/17425255.2018.1417388
Tipo di file: PDF EDITORIALE
Dimensione 1.13 MB
Formato Adobe PDF
  Visualizza/Apri   Richiedi una copia
1.13 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1671338
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 16
social impact